Basel, Switzerland (GenevaLunch) – Pharmaceuticals multinational Roche reports sales for the first nine months of 2009 up 11 percent in local currencies and 9 percent in Swiss francs, with both its pharmaceutical and diagnostics divisions outperforming the market, the company says. Sales rose by CHF3.1 billion to 36.4 billion. The company has revised upwards its forecast for growth in 2009, to “at least high single-digit full-year sales growth for [the] pharmaceuticals division; full-year 2009 sales in both divisions expected to grow well ahead of market.”
Posted by Ellen Wallace on 15 October 2009 at 10:20 |
permalink
This work by genevalunch.com is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported.
News story, GenevaLunch, 15 October 2009.
Filed under: Business
Tags: 2009 results, Basel, Roche, sales
You can leave a response, or trackback from your own site.
We are happy to have your comments,
which are approved before they appear: please remember to be courteous and brief.
We accept only comments directly related to an article. We do not accept comment
spam - messages sent to more than one site. We do not publish comments if the
e-mail address is not legitimate. Thank you!